m6A-centered Drug Response Information

General Information of the Drug (ID: M6APDG02309)
Name
Asp-BrPmp-Leu
Synonyms
Asp-BrPmp-Leu; CHEMBL1289231; BDBM50331945
    Click to Show/Hide
Status
Investigative
Structure
Formula
C20H29BrN3O9P
InChI
1S/C20H29BrN3O9P/c1-10(2)7-15(20(29)30)24-19(28)14(23-18(27)13(22)9-16(25)26)8-11-3-5-12(6-4-11)17(21)34(31,32)33/h3-6,10,13-15,17H,7-9,22H2,1-2H3,(H,23,27)(H,24,28)(H,25,26)(H,29,30)(H2,31,32,33)/t13-,14-,15-,17?/m0/s1
InChIKey
VZSILTSENHCLNI-CKSGOKGCSA-N
PubChem CID
52949968
TTD Drug ID
D0N7VL
Target Gene(s) and Their Upstream m6A Regulator, Together with the Effect of Target Gene(s) in Drug Response
The target genes involved in drug-target interaction (such as drug-metabolizing enzymes, drug transporters and therapeutic targets) and drug-mediated cell death signaling (including modulating DNA damage and repair capacity, escaping from drug-induced apoptosis, autophagy, cellular metabolic reprogramming, oncogenic bypass signaling, cell microenvironment, cell stemness, etc.) could be regulated by m6A regulator(s) and affected their corresponding drug response. You can browse detailed information on drug-related target gene(s) mediated by m6A regulators.
Leukocyte common antigen (PTPRC)
Heterogeneous nuclear ribonucleoproteins A2/B1 (HNRNPA2B1)
In total 1 mechanisms lead to this potential drug response
 Regulator Info 
Response Summary Leukocyte common antigen (PTPRC) is a therapeutic target for Asp-BrPmp-Leu. The Heterogeneous nuclear ribonucleoproteins A2/B1 (HNRNPA2B1) has potential in affecting the response of Asp-BrPmp-Leu through regulating the expression of Leukocyte common antigen (PTPRC). [1], [2]
Heterogeneous nuclear ribonucleoproteins C1/C2 (HNRNPC)
In total 1 mechanisms lead to this potential drug response
 Regulator Info 
Response Summary Leukocyte common antigen (PTPRC) is a therapeutic target for Asp-BrPmp-Leu. The Heterogeneous nuclear ribonucleoproteins C1/C2 (HNRNPC) has potential in affecting the response of Asp-BrPmp-Leu through regulating the expression of Leukocyte common antigen (PTPRC). [1], [2]
References
Ref 1 Roles of the m(6)A Modification of RNA in the Glioblastoma Microenvironment as Revealed by Single-Cell Analyses. Front Immunol. 2022 Apr 26;13:798583. doi: 10.3389/fimmu.2022.798583. eCollection 2022.
Ref 2 CD45 / PTPRC Antibody, Biotin conjugate (OX-30).